Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Furie R, Petri M, Zamani O, et al, “A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus,” Arthritis Rheum , 2011, 63(12):3918-30. [PubMed 22127708 ] Navarra SV, Guzmán RM, Gallacher AE, et al, "Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial," Lancet , 2011, 26(377):721-31. [PubMed 21296403 ] Wallace DJ, Stohl W, Furie RA, et al, "A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus," Arthritis Rheum , 2009, 61(9):1168-78. [PubMed 19714604 ] Topic 16479 Version 25.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0605-201.211.0.116-77C6F20116-S244013.14]